本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2012/6/141 分钟阅读
Guidance for Industry on Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment; Availability; Correction
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 31, 2012 (77 FR 32124). The document announced the availability of a guidance for industry entitled "Irritable Bowel Syndrome--Clinical Evaluation of Drugs for Treatment." The document was published with an incorrect docket number. This document corrects that error.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →